Insulin resistance and impaired insulin secretion due to phosphofructo-1-kinase-deficiency in humans
暂无分享,去创建一个
[1] J. Malin,et al. Muscle phosphofructokinase deficiency in two generations , 1996, Journal of Neurological Sciences.
[2] K. Feldmann,et al. New isoniazid/ethionamide resistance gene mutation and screening for multidrug- resistant Mycobacterium tuberculosis strains , 1995, The Lancet.
[3] D. Bartlett,et al. Reversal of tumor-associated hyperglucagonemia as treatment for cancer cachexia. , 1995, Surgery.
[4] G. Velho,et al. A missense mutation in the glucagon receptor gene is associated with non–insulin–dependent diabetes mellitus , 1995, Nature Genetics.
[5] Y. Yazaki,et al. A subtype of diabetes mellitus associated with a mutation in the mitochondrial gene , 1995, Muscle & nerve. Supplement.
[6] B. Corkey,et al. Phosphofructokinase isozymes in pancreatic islets and clonal beta-cells (INS-1). , 1995, Diabetes.
[7] C. Eng,et al. Common mutations in the phosphofructokinase-M gene in Ashkenazi Jewish patients with glycogenesis VII--and their population frequency. , 1994, American journal of human genetics.
[8] C. R. Kahn,et al. Insulin Action, Diabetogenes, and the Cause of Type II Diabetes , 1994, Diabetes.
[9] D. Accili,et al. Insulin Resistance or Insulin Deficiency: Which Is the Primary Cause of NIDDM? , 1994, Diabetes.
[10] S. Kageyama,et al. Insulin sensitivity test using a somatostatin analogue, octreotide (Sandostatin). , 1994, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.
[11] S. Nagataki,et al. Cloning of a complete protein-coding sequence of human platelet-type phosphofructokinase isozyme from pancreatic islet. , 1994, Biochemical and biophysical research communications.
[12] M. Permutt,et al. Polymorphic Microsatellite Repeat Markers at the Glucokinase Gene Locus Are Positively Associated With NIDDM in Japanese , 1993, Diabetes.
[13] Y. Yazaki,et al. Polymorphism of the glycogen synthase gene and non-insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.
[14] P. Froguel,et al. Polymorphism of the glycogen synthase gene and non-insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.
[15] L. Groop,et al. Association between polymorphism of the glycogen synthase gene and non-insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.
[16] M. Permutt,et al. Glucokinase and NIDDM: A Candidate Gene That Paid Off , 1992, Diabetes.
[17] J. Maassen,et al. Mutation in mitochondrial tRNALeu(UUR) gene in a large pedigree with maternally transmitted type II diabetes mellitus and deafness , 1992, Nature Genetics.
[18] M. Permutt,et al. Glucokinase Gene is Genetic Marker for NIDDM in American Blacks , 1992, Diabetes.
[19] R. O’Brien,et al. Molecular Physiology and Genetics of NIDDM: Importance of Metabolic Staging , 1992, Diabetes Care.
[20] R. DeFronzo,et al. Pathogenesis of NIDDM: A Balanced Overview , 1992, Diabetes Care.
[21] H. Yki-Järvinen. Glucose toxicity. , 1992, Endocrine reviews.
[22] S. Lillioja,et al. Basal and insulin-mediated carbohydrate metabolism in human muscle deficient in phosphofructokinase 1. , 1991, The American journal of physiology.
[23] R. Haller,et al. Glucose-induced exertional fatigue in muscle phosphofructokinase deficiency. , 1991, The New England journal of medicine.
[24] S. Massry,et al. Inhibition of phosphofructokinase activity in pancreatic islets in phosphate depletion. , 1991, Mineral and electrolyte metabolism.
[25] S. Massry,et al. Phosphate depletion impairs insulin secretion by pancreatic islets. , 1991, Kidney international.
[26] D. Owens,et al. INSULIN DEFICIENCY IN NON-INSULIN-DEPENDENT DIABETES , 1989, The Lancet.
[27] R. DeFronzo. The Triumvirate: β-Cell, Muscle, Liver: A Collusion Responsible for NIDDM , 1988, Diabetes.
[28] R. DeFronzo. Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM. , 1988, Diabetes.
[29] T. Kasten,et al. Analysis of the phosphofructokinase subunits and isoenzymes in human tissues. , 1988, The Biochemical journal.
[30] Marinos C. Dalakas,et al. Muscle biopsy — a practical approach , 1986, The Ulster Medical Journal.
[31] B V Howard,et al. Relationships between insulin secretion, insulin action, and fasting plasma glucose concentration in nondiabetic and noninsulin-dependent diabetic subjects. , 1984, The Journal of clinical investigation.
[32] S. Dimauro,et al. Heterogeneity of the molecular lesions in inherited phosphofructokinase deficiency. , 1983, The Journal of clinical investigation.
[33] G. Baule,et al. Hemoglobin A1 in subjects with G-6-PD deficiency during and after hemolytic crises due to favism. , 1983, Acta haematologica.
[34] P. Marbach,et al. SMS 201-995: a very potent and selective octapeptide analogue of somatostatin with prolonged action. , 1982, Life sciences.
[35] G. Reaven,et al. Assessment of Insulin Resistance with the Insulin Suppression Test and the Euglycemic Clamp , 1981, Diabetes.
[36] E. Van Schaftingen,et al. Is the glucose‐induced stimulation of glycolysis in pancreatic islets attributable to activation of phosphofructokinase by fructose 2,6‐bisphosphate? , 1981, FEBS letters.
[37] A. Goldhammer,et al. Phosphofructokinase: structure and function. , 1979, Current topics in cellular regulation.
[38] J. Kaplan,et al. International Committee for Standardization in Haematology: Recommended Methods for Red‐Cell Enzyme Analysis * , 1977, British journal of haematology.
[39] D. Porte,et al. Relationships between fasting plasma glucose levels and insulin secretion during intravenous glucose tolerance tests. , 1976, The Journal of clinical endocrinology and metabolism.
[40] E. Bonilla,et al. Histochemical diagnosis of muscle phosphofructokinase deficiency. , 1970, Archives of neurology.
[41] R. Layzer,et al. Muscle phosphofructokinase deficiency. , 1967, Archives of neurology.
[42] C. Angelini,et al. Enzymes of the glycogen cycle and glycolysis in various human neuromuscular disorders. , 1967, Journal of neurology, neurosurgery, and psychiatry.
[43] R. Harbeck,et al. Influence of age on intravenous glucose tolerance and serum immunoreactive insulin. , 1966, Lancet.
[44] T. Tanaka,et al. PHOSPHOFRUCTOKINASE DEFICIENCY IN SKELETAL MUSCLE. A NEW TYPE OF GLYCOGENOSIS. , 1965, Biochemical and biophysical research communications.